ResMed (RMD) Tops Q3 EPS by 20c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $228.35 -0.37%
EPS Growth %: +5.5%
Financial Fact:
Basic weighted average shares outstanding: 140.79M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +5.5%
Financial Fact:
Basic weighted average shares outstanding: 140.79M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q3 EPS of $2.13, $0.20 better than the analyst estimate of $1.93. Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $1.17 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Goldman Sachs Downgrades Shurgard Self Storage SA (SHUR:BB) to Neutral
- ICICI Bank (ICICIBC:IN) (IBN) PT Raised to INR2,000 at Goldman Sachs
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
